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Wegener’s Granulomatosis (WG) is characterized by necrotizing granulomas and vasculitis. 
If left untreated, the prognosis is poor - a 90% mortality rate within 2 years. Several authors have 
described the otologic manifestations of WG; these authors, however, have not mentioned the stage 
of the disease in which these findings present - whether as initial manifestations or subsequent to 
other findings.
Aim: To describe three confirmed cases of WG with mastoiditis as the first manifestation, progressing 
to peripheral facial paralysis (PFP).
Material and Method: A clinical series study. Patients diagnosed with WG that initially presented 
with otologic findings are described.
Results: The three cases presented with unilateral otalgia, otorrhea, and hearing loss associated 
with ipsilateral PFP. None recovered in spite of the treatment; an investigation of associated diseases 
was therefore undertaken. Positive ANCA-C titers where detected in all patients, confirming the 
diagnosis of WG. Clinical improvement was seen after treatment of WG; the PFP regressed and 
hearing thresholds improved partially.
Conclusion: Complications of otitis media (mastoiditis and PFP) that do not respond to the usual 
treatment require an investigation of associated diseases; WG should be included for an early diagnosis 
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INTRODUCTION
Wegener’s granulomatosis is an idiopathic sys-
temic form of vasculitis characterized by the presence 
of necrotizing granulomas and vasculitis in the upper 
airways, lower airways and kidneys; however, as it is a 
systemic disease, it may involve any organ. Etiology is yet 
undefined, but it appears to be a disease of autoimmune 
nature1,2. As it is a rare disease, its actual incidence cannot 
be precisely determined1. It is estimated that prevalence 
ratios revolve around 3:100.000 inhabitants, with males 
and females being equally involved. Incidence peaks 
between the ages of 20 and 40 years2. Prognosis is 
poor, as the disease presently has no treatment. Ninety 
percent of the patients die within two years. Nonethe-
less, if therapy is offered early on (before kidney injury 
onset) with immunosuppressants, long term remission 
is reached for 90% of the patients1.
ENT manifestations are present in the vast major-
ity of patients (73-99%), and are usually among the first 
symptoms to set in. Therefore, ENT physicians have a 
determining role in recognizing the early onset of the 
disease and starting the proper therapy. Occasionally, 
ear conditions are the first and only to appear3. They 
are present in 20-61% of the cases4, otitis media with 
effusion being the most common manifestation2. Vari-
ous authors cite ear manifestations in the progress of 
Wegener’s granulomatosis; however, they fail to specify 
when such manifestations set in as part of the disease, 
i.e., either early on or subsequently to other findings3.
This paper aims to offer an update on the possible 
early isolated clinical manifestations of ear injury con-
nected to Wegener’s granulomatosis. The cases of three 
patients diagnosed with Wegener’s granulomatosis are 
described, showing mastoiditis at first and then peripheral 
facial nerve palsy. The patients’ clinical and audiometric 
progress is also discussed, alongside the time needed to 
reach a firm diagnosis.
MATERIALS AND METHODS
This stud comprises a series of cases f patients 
diagnosed with Wegener’s granulomatosis with early 
ear manifestations. The results of lab, audiometry, and 
imaging tests were analyzed, as well as patient clinical 
progress. This study was submitted and approved by the 




RCTD, 52, female, was having intense left ear 
otalgia and rhinorrhea for 20 days. She had been un-
successfully treated with amoxicillin and had her pain 
improved after taking intramuscular ceftriaxone. How-
ever, she developed left peripheral facial nerve palsy 
and came to be seen at our service. Her facial nerve 
palsy was categorized as grade III (House-Brackmann) 
and otoscopic examination showed a perforated tym-
panic membrane with effusion. The rest of her test was 
normal. She was diagnosed with acute otitis media and 
peripheral facial nerve palsy. CBC, audiometry, and 
temporal bone CT scans were ordered. The patient was 
prescribed ciprofloxacin and oral steroids. Audiometry 
tests showed moderate to severe mixed hearing loss on 
the left ear and CT scans revealed opacification of the 
mastoid air cells and the tympanic cavity, with preserved 
bone septations consistent with acute otomastoiditis. 
Effusion had ceased and facial nerve palsy had almost 
entirely regressed two weeks into therapy (the patient still 
had minor lower lip asymmetry). Otoscopic examination 
showed bilaterally preserved tympanic membranes but 
a thickened left eardrum. Control audiometry revealed 
worsened hearing thresholds (Figure 1) and profound 
mixed hearing loss in the left ear. An MRI of the inner 
ear was ordered.
Figure 1. Left ear profound mixed hearing loss; PB max could not 
be verified.
In the next visit the patient complained or hear-
ing loss in the right ear. Her MRI scans showed marked 
contrast enhancement in the cochlea and in the left facial 
nerve, ipsilateral mastoid opacification, (Figure 2), and a 
left parapharyngeal lymphnode (Figure 3). Audiometry 
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Case 2
JCM, 31, male, was having otalgia, hypacusis and 
effusion on the left eat for one month. One week after 
the commencement of symptoms, he presented right 
nasal obstruction with hyaline rhinorrhea. The patient 
looked for care at another service and was diagnosed 
with acute rhinosinusitis and treated with antibiotics (he 
could not tell which) for 14 days with no improvement. 
He started coughing insistently and decided to look for 
our service. Left year otoscopic examination revealed a 
reddish thickened eardrum with effusion in the outer 
ear canal, but no perforation was seen. The patient 
was treated with cefuroxime axetil and topical cipro-
floxacin on his left ear. He came back three days later 
with peripheral facial palsy (House-Brackmann’s grade 
IV). Temporal bone CT scans revealed opacification 
involving the left middle ear and mastoid cells without 
signs of osteolytic injury (Figure 5), the sphenoid sinus 
bilaterally, the right maxillary and ethmoid sinuses, and 
matter with soft tissue density in the right nasal cav-
ity. Endoscopic examination showed only a yellowish 
secretion in the right middle meatus. The patient was 
diagnosed with acute otomastoiditis with peripheral 
facial nerve palsy. He was hospitalized and treated with 
ceftriaxone, clindamycin, and dexamethasone. His CBC 
suggested leukocytosis (14000) without shifting to the 
left; eosinophilia, kidney function, ESR, electrolytes, and 
Figure 2. T1-weighed head MRI scan, axial view after contrast has been 
injected at the level of the inner ear canal; intense contrast uptake seen 
in the left ear’s cochlea and mastoid cells.
Figure 3. T1-weighed head MRI scan, coronal view after contrast 
injection; expansive injury seen on the left side wall f the rhinopharynx 
consistent with reactive lymphnode. The arrows indicate shifting of 
adjacent parapharyngeal fat.
then revealed right ear conductive hearing loss. The pa-
tient was hospitalized for etiology investigation. During 
her stay the patient had fever episodes. Her CBC was 
negative, her CSF was normal and free of infection, and 
her ESR was elevated (140). The patient was analyzed for 
infectious and rheumatic disease and was suspected for 
granuloma. His c-ANCA was titrated at 1/160, confirming 
the diagnosis of Wegener’s granulomatosis three months 
after the onset of symptoms. Chest CT scans revealed the 
presence of lung parenchymal nodules. Therapy with 
deflazacort and cyclophosphamide was initiated, and the 
patient partially recovered her hearing thresholds (Figure 
4), as inflammation in the middle ear was controlled.
Figure 4. Audiometry after therapy. Left ear mild to moderate mixed 
hearing loss, with marked improvement on speech discrimination.
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see mastoid cells filled with some whitish hard material 
and brittle bone tissue. Biopsies were done on the right 
nasal cavity. Pathology tests suggested chronic inflam-
matory process with presence of eosinophils. Temporal 
bone osteomyelitis was considered, and after discussing 
the case with the institution’s infectologist, we opted to 
initiate therapy with cefepime. While the patient was 
hospitalized, serology tests for HIV, hepatitis B and C, 
VDRL, rheumatoid factor, c-ANCA, and p-ANCA. All came 
back negative. The rheumatologist was once again called 
to assess the patient and ordered a c-ANCA test that this 
time came back positive, with a titration of 1/20. The pa-
tient was prescribed cyclophosphamide 100mg/day and 
prednisone 70mg/day. Chest CT scans showed multiple 
parenchymal lung nodules. Diagnosis as established 74 
days after symptom onset. The patient recovered com-
pletely from facial nerve palsy and improved his hearing 
thresholds only partially (Figure 7).
Figure 5. Temporal bone CT scan, axial view showing matter with soft 
tissue density on the mastoid and in the left middle ear and sphenoidal 
sinus.
Figure 6. Left ear severe mixed hearing loss.
coagulation were normal; audiometry revealed moderate 
left ear mixed hearing loss. The patient was discharged 
after spending six days in hospital and was sent home 
with a prescription for antibiotics.
In his follow-up visit the patient complained of 
otalgia, vertigo episodes, and worsening hearing loss. 
Audiometry showed his tone thresholds had deteriorated 
(Figure 6). A tympanomastoidectomy was performed on 
the patient’s left ear and the lesions found in the right 
nasal cavity were biopsied. During surgery we could 
Figure 7. Left ear mild to moderate mixed hearing loss.
Case 3
A Caucasian female patient aged 42 was having 
intense otalgia and purulent effusion in her right ear for 
45 days. She started treatment for otitis media with ef-
fusion with antibiotics (amoxicillin-clavulanic acid and 
ciprofloxacin) and both systemic and topical steroids, 
but her condition worsened, as hypacusis, vertigo and 
headaches set in. Twenty days later she was hospital-
ized and given antibiotics (ceftriaxone) and intravenous 
steroids. However, the broad spectrum antibiotics and 
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steroids led to no improvement in her condition. As part 
of her history, she had an unidentified renal disorder and 
a sister who had undergone kidney transplantation. Oto-
scopic examination revealed a central perforation on her 
right eardrum, on which a reddish polypoid tumor and 
purulent effusion could be observed. The remainder of 
her ENT tests were normal. Audiometry showed right ear 
mixed dysacusis (Figure 8). Temporal bone CT and head 
MRI scans showed complete opacification of the mastoid 
and the right middle ear associated with otomastoiditis.
Figure 8. Right ear severe to profound mixed hearing loss.
Figure 9. Right ear moderate to severe mixed hearing loss, with im-
proved speech discrimination.
Effusion culture findings revealed growing pneu-
mococcus sensitive to the antibiotics used to treat her; 
CBC showed neutrophilia and shift to the left, elevated 
ESR, and proteinuria. As the patient did not respond to 
drug therapy, she was referred to tympanomastoidectomy 
and placement of a ventilation tube to the right to try 
and resolve the inflammatory process and collect mate-
rial for more culturing and histology studies. Seven days 
after surgery the patient presented progressive peripheral 
facial nerve palsy (her electroneurogram showed very 
low potentials and complete nerve degeneration), left 
ear hearing loss, dyspnea when physically strained, and 
bloody rhinorrhea. Nasal endoscopy revealed ulcerated 
bilateral lesions covered by fibrin on the torus tubarius 
and on the side wall of the right nasal cavity. X-rays and 
chest CT scans showed the presence of infiltrate and 
nodules on both lungs.
Pathology tests run on collected mastoid speci-
mens indicated the presence of granulomas.
C-ANCA was positive to titrations of up to 1/160, 
thus confirming the diagnosis of Wegener’s granulo-
matosis two months after symptom onset. The patient 
was prescribed deflazacort and cyclophosphamide and 
improved significantly from her systemic involvement 
and recovered gradually from both the facial nerve palsy 
and the hearing impairment (Figure 9).
DISCUSSION
Wegener’s granulomatosis is a relatively rare 
condition4. Godman & Churg5 have established the 
criteria to diagnose the disease: 1) granuloma in upper 
airways; 2) necrotizing vasculitis; 3) glomerulonephritis. 
Limited forms of the disease were described later by 
other authors6,7. Most of them presented head and neck 
involvement. The nose and the paranasal sinuses are the 
most frequently involved sites and account for as many 
as 90% of the cases.
Ear disorders are observed in 20-61% of the cases4, 
and rarely are the first and only manifestation7. These 
disorders have been categorized as follows: 1) otitis 
media with effusion (OME); 2) chronic otitis media 
(COM); 3) sensorineural dysacusis (SND)8. Most patients 
with Wegener’s granulomatosis accompanied by ear 
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involvement have otitis media with effusion caused by 
eustachian tube disorders. Primary involvement of the 
nasal cavity and paranasal sinuses with nasopharyngeal 
inflammation have been proposed to account for the 
eustachian tube disorders seen in these patients, who 
usually respond poorly to OME drug therapy and un-
dergo the placement of ventilation tubes7, as also seen 
in the cases presented herein. We therefore stress that 
in cases of persisting OME in adult patients with no his-
tory of eustachian tube disorder the ENT physician must 
thoroughly examine the nasopharynx before placing 
ventilation tubes. Chronic otitis media occurs conse-
quently to the direct involvement of the middle ear and 
the mastoid cavity by necrotizing granuloma9, and may 
develop accompanied by effusion, mastoiditis, and facial 
nerve palsy. Otomastoiditis associated with facial nerve 
palsy is seen in 10% of the cases2,4. In our case base all 
patients evolved this way, without however presenting 
other previous symptoms, as reported few times in the 
literature3,7,9.
Several authors recommend that such complica-
tions be managed conservatively only, as the nerve 
function is recovered in most cases, thus challenging the 
efficacy of surgery2,4,7. Nonetheless, when such compli-
cations are the first manifestations of the disease, early 
diagnosis is extremely difficult to produce. Therefore, 
we believe that many patients with Wegener’s granu-
lomatosis will still undergo mastoidectomy, mainly in 
limited forms of the disease in which the degree of 
clinical suspicion is even lower as also argued by Da-
gum et al.9. The surgical findings seen in cases 2 and 3 
described in this study (obliteration of mastoid cells by 
granulation tissue) are very similar to those reported by 
other authors3,9. One study reported that a patient with 
post-mastoidectomy facial nerve palsy recovered after 
he was treated with immunosuppressants4, as also seen 
in our case 3.
The SND mode of action in patients with We-
gener’s granulomatosis is yet unclear. Some have pos-
tulated that the vasa nervorum and the cochlear vessels 
are affected by vasculitis, or that immune complexes 
deposit on the labyrinth to trigger true immune-mediated 
labyrinthitis, or even that they are adversely affected 
by the toxic effects of inflammation byproducts arising 
from the middle ear through the round window4,9,10. One 
should stress that these patients rarely show vestibular 
symptoms such as vertigo and nystagmus, and that sen-
sorineural hearing loss usually sets in gradually within 
days to weeks10. This pattern of hearing loss was seen 
in all three cases described in this paper, and served as 
a warning sign that led us to keep on investigating the 
condition’s etiology. The presence of serum eosinophilia 
and eosinophils in the pathology tests on case 2 pointed 
to Churg-Strauss syndrome, a condition characteristically 
accompanied by peripheral eosinophilia and eosinophilic 
tissue infiltrate11. However, after the c-ANCA titration 
came back positive, the diagnosis of Wegener’s granu-
lomatosis was confirmed.
Wegener’s granulomatosis must be considered 
when patients do not improve as expected despite being 
given adequate treatment, when they have unspecific 
systemic symptoms suggesting systemic disease (fever, 
myalgia, arthralgia), or when other organs are involved 
(eyes, kidneys, lungs and others). Prolonged evolution 
times of over 20 days to observe regression of ear inflam-
mation suggests a specific etiology to support disease 
activity. Histopathological analysis of biopsy material is 
an important diagnostic tool; the following are usually 
found: small vessel vasculitis, granuloma, necrosis, and 
microabscesses12. However, one can rarely obtain a large 
enough sample and multiple procedures are required, as 
biopsies are inconclusive in over 50% of the times. The 
paranasal sinuses are the preferred biopsy sites2. The 
determination of serum levels of cytoplasmic antineu-
trophil cytoplasmic antibodies (c-ANCA) revolutionized 
the diagnosis of Wegener’s, boasting specificity of 99%. 
A positive test result practically confirms the diagnosis. 
Sensitivity depends on how active and extensive the 
disease is, and values can get to as high as 93% during 
the condition’s active phase8. Limited manifestations 
have a high rate of false negatives (30%). However, 
when there is suspicion, it is recommended to perform 
a series of titrations2.
Wegener’s granulomatosis is a lethal disease if left 
untreated. Therapy consists of steroids and immuno-
suppressants such as cyclophosphamide, azathioprine, 
and methotrexate. Long term remission is achieved in 
up to 90% of the cases, especially in the absence of 
kidney injury1. Controversy still looms over the use of 
trimethoprim/sulfamethoxazole to induce remission in 
refractory patients and to maintain remission1.
CONCLUSIONS
Complications from acute otitis media (mastoiditis 
and peripheral facial nerve palsy) refractory to usual 
drug therapy require the investigation of granulomatous 
diseases. Wegener’s granulomatosis must be considered 
so that early diagnosis is made possible and a better 
prognosis is offered to those affected by this disease.
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